Immunization News and Research

RSS

Pennsylvania allocated 566,000 doses of H1N1 vaccine

The Department of Health today announced the Centers for Disease Control and Prevention, or CDC, has allocated more than 566,000 doses of H1N1 vaccine to Pennsylvania. While delays in vaccine production have occurred, the department is placing orders as soon as vaccine is allocated to ensure it reaches Pennsylvania residents as quickly as possible.

24 Oct 2009

Media examines U.S., Mexico H1N1 vaccine campaigns, health effects of handwashing in Bolivia

The Washington Post examines H1N1 vaccine supplies across the U.S.: "With only a fraction of the tens of millions of doses of vaccine that authorities predicted would be available arriving in states, cities and towns, public health officials who spent months planning for a massive immunization program are instead scrambling to parcel out their limited supply of nasal sprays and shots," the newspaper writes.

24 Oct 2009

News outlets examine challenges with expanding global child immunization campaigns

Wednesday's release of the WHO, UNICEF and the World Bank joint report on childhood vaccines highlighted gains in recent global vaccination campaigns and also found that nearly 24 million infants worldwide don't get the recommended first-year vaccination.

23 Oct 2009

45% of American adults not inclined to get vaccinated against seasonal flu

Two in five at-risk American adults who would benefit from vaccination against seasonal flu are missing out on the protective shots because they believe they do not need them and are not inclined to be vaccinated. And among those who say they do intend to take up the vaccine, nearly half get around to it, according to Dr. Katharine Harris from the RAND Corporation in Arlington, USA, and her team.

23 Oct 2009

More infants are being immunized but funding gap leaves millions of children still at risk

Reversing a downward trend, immunization rates are now at their highest ever and vaccine development worldwide is booming, according to a new assessment released today by the World Health Organization (WHO), UNICEF and the World Bank.

22 Oct 2009

Advisory Committee on Immunization Practices supports the permissive use of GARDASIL

Merck & Co., Inc. announced today that the U.S. Centers for Disease Control and Prevention’s (CDC’s) Advisory Committee on Immunization Practices (ACIP) supports the permissive use of GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] for boys and young men ages 9 to 26, which means that GARDASIL may be given to males ages 9 to 26 to reduce the likelihood of acquiring genital warts at the discretion of the patient's health care provider.

22 Oct 2009

CDC urges heart disease patients get vaccinated against the flu each year

Cardiovascular disease was the leading cause of death in Florida in 2005, accounting for approximately 35 percent of all deaths in the state. People with heart disease are at a high risk for serious and potentially life-threatening complications from the flu.

22 Oct 2009

GlaxoSmithKline's CERVARIX recommended by CDC for protection against cervical cancer

GlaxoSmithKline announced today that the U.S. Centers for Disease Control and Prevention's (CDC's) Advisory Committee on Immunization Practices (ACIP) recommended that CERVARIX® [Human papillomavirus bivalent (types 16 and 18) vaccine, recombinant] be given to girls and young women to protect against cervical pre-cancers and cervical cancer caused by oncogenic HPV 16 and 18.

22 Oct 2009

106m infants worldwide received vaccines last year, coverage gaps remain, report says

A joint report by the WHO, UNICEF and the World Bank on worldwide vaccination efforts released Wednesday found "a record 106 million infants were vaccinated last year against life-threatening diseases, but nearly a fifth of the world's babies still are not protected fully," the Associated Press reports.

22 Oct 2009

Clinical data supports continued development of ORENCIA administration for rheumatoid arthritis

Bristol-Myers Squibb Company announced today that new clinical data support continued development of a subcutaneous administration of ORENCIA® (abatacept) for patients with moderate to severe rheumatoid arthritis.

21 Oct 2009

Bill & Melinda Gates Foundation's initiative to transform health in developing countries

The Bill & Melinda Gates Foundation today announced 76 grants of US$100,000 each to pursue bold ideas for transforming health in developing countries. The grants support researchers across 16 countries, including nine in Europe and Africa with ideas as diverse as using the power of sunlight to kill malaria-causing mosquito larvae and developing a device that repels mosquitoes without insecticides.

21 Oct 2009

Members of Humana to receive coverage for the administration cost of H1N1 vaccine

Humana Inc. today announced that the company will cover the administration cost of the H1N1 (swine flu) vaccine for all fully insured members including those members who have a benefit plan that excludes immunization coverage. All co-payment, coinsurance and deductibles will be waived for the administration of the H1N1 vaccination regardless of the preventative-services benefit currently provided in these members’ plans.

21 Oct 2009

Bristol-Myers Squibb presents study data on ORENCIA for treating rheumatoid arthritis

Bristol-Myers Squibb Company today announced two-year results of a study that supports use of ORENCIA® (abatacept) for methotrexate-naive patients with moderate to severe rheumatoid arthritis of less than or equal to two years duration.

20 Oct 2009

ImmunoCellular Therapeutics files a provisional patent application

ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company that is developing immune-based therapies for the treatment of brain and other cancers, announced today that it has filed a provisional patent application at US Patent Office seeking protection of intellectual property relating to novel glycosylated epitopes present in lung cancer, pancreatic cancer and colon cancer that are targeted by the Company’s ICT-109 monoclonal antibody product candidate.

20 Oct 2009

Potential hazards of H1N1 vaccine and seasonal flu shot not disclosed, say protesters

As millions of Americans remain concerned about government-recommended flu shots, dozens of citizens dressed in full haz-mat suits will gather Wednesday, October 21, at the entrance to the Centers For Disease Control (CDC) to greet arriving members of the Advisory Committee on Immunization Practices.

20 Oct 2009

Novel H1N1 influenza raises parents' awareness and concern about seasonal influenza

Novel H1N1 influenza has raised parents' awareness and concern about seasonal influenza, increasing the likelihood that they will get their children vaccinated compared to past years, according to a recent national survey commissioned by the National Foundation for Infectious Diseases (NFID).

20 Oct 2009

Vaccinations and preventative hygiene routines can help protect families from H1N1

According to the Centers for Disease Control and Prevention (CDC), 37 states in the U.S. now report widespread influenza activity - and nearly all influenza cases reported to the health authority are 2009 H1N1, also known as swine flu. However, with the release of a 2009 H1N1 vaccine this week, parents have a new preventative tool to help keep their families safe from illness.

19 Oct 2009

Research study on cowpox virus

In the annals of medicine, Edward Jenner's 1796 vaccination of a young boy against smallpox, using fluid from cowpox blisters, remains a landmark case. In a new study, Kathryn Sykes, a researcher at Arizona State University's Biodesign Institute and her colleagues have taken a fresh look at cowpox.

19 Oct 2009

WHO, UNICEF publish plan to reduce childhood diarrhea deaths

The WHO and UNICEF have released a seven-point treatment and prevention plan to reduce the number of children around the world who die from diarrhea, the BBC reports (10/14). BMJ News writes, "Every year 1.5 million children aged under 5 years die from diarrhoea, more than 80% of them in Africa and south Asia" (Zarocostas, 10/14).

19 Oct 2009

GlaxoSmithKline receives FDA approval for cervical cancer vaccine

GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has approved CERVARIX® [Human papillomavirus bivalent (types 16 and 18) vaccine, recombinant] for the prevention of cervical pre-cancers and cervical cancer associated with oncogenic human papillomavirus (HPV) types 16 and 18 for use in girls and young women (aged 10-25).

19 Oct 2009

Immunization News and Research

Pennsylvania allocated 566,000 doses of H1N1 vaccine

Media examines U.S., Mexico H1N1 vaccine campaigns, health effects of handwashing in Bolivia

News outlets examine challenges with expanding global child immunization campaigns

45% of American adults not inclined to get vaccinated against seasonal flu

More infants are being immunized but funding gap leaves millions of children still at risk

Advisory Committee on Immunization Practices supports the permissive use of GARDASIL

CDC urges heart disease patients get vaccinated against the flu each year

GlaxoSmithKline's CERVARIX recommended by CDC for protection against cervical cancer

106m infants worldwide received vaccines last year, coverage gaps remain, report says

Clinical data supports continued development of ORENCIA administration for rheumatoid arthritis

Bill & Melinda Gates Foundation's initiative to transform health in developing countries

Members of Humana to receive coverage for the administration cost of H1N1 vaccine

Bristol-Myers Squibb presents study data on ORENCIA for treating rheumatoid arthritis

ImmunoCellular Therapeutics files a provisional patent application

Potential hazards of H1N1 vaccine and seasonal flu shot not disclosed, say protesters

Novel H1N1 influenza raises parents' awareness and concern about seasonal influenza

Vaccinations and preventative hygiene routines can help protect families from H1N1

Research study on cowpox virus

WHO, UNICEF publish plan to reduce childhood diarrhea deaths

GlaxoSmithKline receives FDA approval for cervical cancer vaccine

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News